title: The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.
abstract: An interdisciplinary European group of clinical experts in the field of movement disorders and experienced Botulinum toxin users has updated the consensus for the use of Botulinum toxin in the treatment of children with cerebral palsy (CP). A problem-orientated approach was used focussing on both published and practice-based evidence. In part I of the consensus the authors have tabulated the supporting evidence to produce a concise but comprehensive information base, pooling data and experience from 36 institutions in 9 European countries which involves more than 10,000 patients and over 45,000 treatment sessions during a period of more than 280 treatment years. In part II of the consensus the Gross Motor Function Measure (GMFM) and Gross Motor Function Classification System (GMFCS) based Motor Development Curves have been expanded to provide a graphical framework on how to treat the motor disorders in children with CP. This graph is named "CP(Graph) Treatment Modalities - Gross Motor Function" and is intended to facilitate communication between parents, therapists and medical doctors concerning (1) achievable motor function, (2) realistic goal-setting and (3) treatment perspectives for children with CP. The updated European consensus 2009 summarises the current understanding regarding an integrated, multidisciplinary treatment approach using Botulinum toxin for the treatment of children with CP.
authors.affiliation: Department of Paediatric Neurology and Developmental Medicine, Dr. von Hauner's Children's Hospital, University of Munich, Lindwurmstr. 4, 80337 Munich, Germany.
authors.forename: Florian
authors.initials: F
authors.lastname: Heinen
authors.forename: Kaat
authors.initials: K
authors.lastname: Desloovere
authors.forename: A Sebastian
authors.initials: AS
authors.lastname: Schroeder
authors.forename: Steffen
authors.initials: S
authors.lastname: Berweck
authors.forename: Ingo
authors.initials: I
authors.lastname: Borggraefe
authors.forename: Anya
authors.initials: A
authors.lastname: van Campenhout
authors.forename: Guro L
authors.initials: GL
authors.lastname: Andersen
authors.forename: Resa
authors.initials: R
authors.lastname: Aydin
authors.forename: Jules G
authors.initials: JG
authors.lastname: Becher
authors.forename: Günther
authors.initials: G
authors.lastname: Bernert
authors.forename: Ignacio Martinez
authors.initials: IM
authors.lastname: Caballero
authors.forename: Lucinda
authors.initials: L
authors.lastname: Carr
authors.forename: Emmanuelle Chaleat
authors.initials: EC
authors.lastname: Valayer
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Desiato
authors.forename: Charlie
authors.initials: C
authors.lastname: Fairhurst
authors.forename: Paul
authors.initials: P
authors.lastname: Filipetti
authors.forename: Ralph-Ingo
authors.initials: RI
authors.lastname: Hassink
authors.forename: Ulf
authors.initials: U
authors.lastname: Hustedt
authors.forename: Marek
authors.initials: M
authors.lastname: Jozwiak
authors.forename: Serdar Ibrahim
authors.initials: SI
authors.lastname: Kocer
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Kolanowski
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Krägeloh-Mann
authors.forename: Sehim
authors.initials: S
authors.lastname: Kutlay
authors.forename: Helena
authors.initials: H
authors.lastname: Mäenpää
authors.forename: Volker
authors.initials: V
authors.lastname: Mall
authors.forename: Paul
authors.initials: P
authors.lastname: McArthur
authors.forename: Edith
authors.initials: E
authors.lastname: Morel
authors.forename: Antigone
authors.initials: A
authors.lastname: Papavassiliou
authors.forename: Ignacio
authors.initials: I
authors.lastname: Pascual-Pascual
authors.forename: Søren Anker
authors.initials: SA
authors.lastname: Pedersen
authors.forename: Frank S
authors.initials: FS
authors.lastname: Plasschaert
authors.forename: Irene
authors.initials: I
authors.lastname: van der Ploeg
authors.forename: Olivier
authors.initials: O
authors.lastname: Remy-Neris
authors.forename: Anne
authors.initials: A
authors.lastname: Renders
authors.forename: Guiseppe
authors.initials: G
authors.lastname: Di Rosa
authors.forename: Maja
authors.initials: M
authors.lastname: Steinlin
authors.forename: Kristina
authors.initials: K
authors.lastname: Tedroff
authors.forename: Joan Vidal
authors.initials: JV
authors.lastname: Valls
authors.forename: Elke
authors.initials: E
authors.lastname: Viehweger
authors.forename: Guy
authors.initials: G
authors.lastname: Molenaers
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000592:standards / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000592:standards / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D005060:Europe / Q000453:epidemiology; D006801:Humans; D010372:Pediatrics
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins